Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMCOpen access

The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity

Vincent FB., Saulep-Easton D., Figgett WA., Fairfax KA., Mackay F.

Clinical Trial on Neuroinflammation, Autoimmune Research, published in Cytokine Growth Factor Rev (2013) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Cytokine Growth Factor Rev (2013)
Reported sample size
—
Source database
Europe PMC
PMID
23684423
PMCID
PMC7108297
DOI
10.1016/j.cytogfr.2013.04.003
Citations
352

Abstract (original English)

The BAFF system plays a key role in the development of autoimmunity, especially in systemic lupus erythematosus (SLE). This often leads to the assumption that BAFF is mostly a B cell factor with a specific role in autoimmunity. Focus on BAFF and autoimmunity, driven by pharmaceutical successes with the recent approval of a novel targeted therapy Belimumab, has relegated other potential roles of BAFF to the background. Far from being SLE-specific, the BAFF system has a much broader relevance in infection, cancer and allergy. In this review, we provide the latest views on additional roles of the BAFF system in health and diseases, as well as an update on BAFF and autoimmunity, with particular focus on current clinical trials.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
B-LymphocytesAnimalsHumansBacterial InfectionsVirus DiseasesParasitic DiseasesAsthmaLupus Erythematosus, SystemicGraft vs Host DiseaseRecombinant Fusion Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research